Dotbee.ai

Analysis CIL Nova Petrochemicals Limited (CNOVAPETRO)

5/28/2024

Analysis CIL Nova Petrochemicals Limited (CNOVAPETRO)

Analysis of CIL Nova Petrochemicals Limited (CNOVAPETRO)

CIL Nova Petrochemicals Limited (CNOVAPETRO) has shown a consistent uptrend in its stock price over the past few days. The Relative Strength Index (RSI) values have been indicating that the stock is in the overbought territory, suggesting a potential reversal or consolidation in the near future.

The Moving Average Convergence Divergence (MACD) indicator has been showing positive values, indicating a bullish momentum in the stock. The MACD histogram has also been increasing, further supporting the bullish sentiment.

The Moving Average (MA) indicator, Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have all been trending upwards, indicating a positive trend in the stock price.

Overall, based on the technical indicators, CIL Nova Petrochemicals Limited seems to be in a bullish phase, but investors should be cautious of a potential reversal or consolidation given the overbought RSI values.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided yet. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results for January 31, 2025, were released after hours. The results for October 31, 2024, were not provided at a specific time. The results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company. Here is a summary of the key data points:

1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets TTM: 22.073999%
- Return on Equity TTM: 147.25%

2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Average 10-Day Volume: 52,903,608
- Average 90-Day Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%

3. Valuation Metrics:
- PEG Ratio: 26.213001
- Forward PE: 26.213001
- Trailing PE: 29.428572
- Enterprise Value: $2,948,462,018,560
- Price to Book MRQ: 39.181313
- Price to Sales TTM: 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672

4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $173.6936
- 200-Day Moving Average: $180.7906
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 8.253%

5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5266761603816345%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5108758755701854%

Income statement 💸

Here are the revenue figures for the company over the past four fiscal years:

1. Fiscal Year 2020: Sales of $274,515,000,000
2. Fiscal Year 2021: Sales of $365,817,000,000
3. Fiscal Year 2022: Sales of $394,328,000,000
4. Fiscal Year 2023: Sales of $383,285,000,000

From these figures, we can observe the following trends:
- There was a steady increase in sales from 2020 to 2022, with a significant jump between 2021 and 2022.
- However, in 2023, there was a slight decrease in sales compared to the previous year.

These trends indicate a general growth in revenue over the past few years, with a slight dip in the most recent fiscal year.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently higher than free cash flow, indicating that the company is generating sufficient cash from its core operations.
3. The company has been paying a significant amount in income taxes each year, with the highest amount paid in 2021.
4. The company has been consistently paying interest on its debts, with a slight increase in interest paid in 2023 compared to previous years.
5. The company has been repurchasing common stock and paying dividends, indicating a return of value to shareholders.
6. The company's end cash position has been fluctuating, reaching its highest value in 2020.
7. The company has been involved in investing activities such as acquisitions, capital expenditures, and the sale/purchase of investments.
8. Financing activities show a mix of debt issuances, repayments, and other financing charges over the years.
9. Overall, the company's cash flow statement reflects a mix of operational, investing, and financing activities that impact its cash position and financial health.

Earnings estimate

Based on analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from a year ago.

2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.

3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.

4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This forecast suggests an increase from the EPS of $6.59 reported for the current fiscal year.

Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth rates expected in the next fiscal year.

Growth estimates

Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.

These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It indicates that analysts are generally optimistic about the company's growth prospects in the near term.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the lowest estimate at $164, the highest at $250, and the average at $202.26. The current price is $191.57, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.

MACD of CNOVAPETRO

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link